Cancer cachexia, a metabolic syndrome causing muscle loss, inflammation, and malnutrition, adversely affects prognosis and treatment in cancer patients.
Despite extensive studies in other malignancies, cachexia remains underexplored in gynecologic cancers, particularly in India.
This study evaluates the cachexia index (CXI) in gynecologic cancer patients and its association with Activin A and Myostatin.
